Summer Sale
50% off Premium Yearly
NYSE:KVUE
Kenvue (KVUE)
Financials 
Technical Analysis 
Jun 11, 2026, 12:00 amThis summary was created by AI, based on 2 opinions in the last 12 months.
Kenvue (KVUE-N) stands out for its strong portfolio of quality essential brands, which consumers trust and utilize regularly. Analysts perceive a positive outlook driven by attractive multiples relative to competitors such as Procter & Gamble (PG) and Colgate (CL). Despite facing challenges, including an unexpected decline in growth and pressure from activists, the stock exhibits resilience, particularly following a leadership change. Furthermore, its strategic partnership with Kimberly-Clark (KMB) hints at potential growth opportunities. With a dividend yield of 4.78% and an analyst price target of $19.23, Kenvue remains a focal point for investors watching the consumer essentials market.
Consumer staples are outperforming in the last few days, and that speaks to the advantage of having a balanced portfolio. Companies like KHC, UL, KVUE, and Nestle. It's not that they won't be affected (their costs would go up), but they're far less cyclical than other businesses. Earnings will be much more stable. Earnings could fall 10%, but not 50%. Dividends will be sustained.
Companies like Unilever and Nestle are huge in NA, but huge globally as well.
An activist investor is inside the company now. Pays a 3.5% dividend. Not followed that much by Wall Street, but offers decent growth.
Lorne SteinbergConsumer health spinoff from J&J. First rate consumer products business. Trading at discount to peers in sector. ~4% dividend attractive. Excellent array of brands in portfolio. Litigation always a concern, but overall not worried for the long term.
Lorne Steinberg
- «
- ‹
- 1
- ›
- »
Kenvue (KVUE) Frequently Asked Questions
What is Kenvue stock symbol?
Kenvue is a American stock, trading under the symbol KVUE (previously KVUE-N on Stockchase) on the New York Stock Exchange (KVUE). It is usually referred to as NYSE:KVUE or KVUE
Is Kenvue a buy or a sell?
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on KVUE (previously KVUE-N on Stockchase). 1 analyst recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Kenvue.
Is Kenvue a good investment or a top pick?
Kenvue was recommended as a Top Pick by Gordon Reid on 2023-09-22. Read the latest stock experts ratings for Kenvue.
Why is Kenvue stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Kenvue.
Is Kenvue worth watching?
Kenvue is followed by 15 investors on Stockchase and is a trending stock that is worth watching.
What is Kenvue stock price?
On 2026-06-12, Kenvue (KVUE) stock closed at a price of $18.14.
Quality, essential brands we love and use daily. Attracted by spinoffs, as they tend to attract interest. Tylenol controversy from Trump pushed price down. Generic brands don't affect many of their products. Attractive multiple compared to PG and CL.
(Analysts’ price target is $19.23)Likes the deal with KMB, which should close sometime next year. Multiple should expand. Not impacted by AI as far as he can tell ;) Yield is 4.78%.